Verastem, Inc. Cash and Restricted Cash
Verastem, Inc. (VSTM) had Cash and Restricted Cash of $136.59 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $136.59M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $165.79M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $205.23M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $137.95M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $136.59M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $165.79M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $205.23M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $137.95M 10-Q · filed 2025-11-04 |
| 2025-06-30 | $164.56M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $117.81M 10-Q · filed 2026-05-07 |
| 2024-12-31 | $89.06M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $113.42M 10-Q · filed 2025-11-04 |
| 2024-06-30 | $83.61M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $82.59M 10-Q · filed 2025-05-13 |
| 2023-12-31 | $79.08M 10-K · filed 2026-03-04 |
| 2023-09-30 | $96.77M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $184.33M 10-Q · filed 2024-08-08 |
| 2023-03-31 | $98.75M 10-Q · filed 2024-05-09 |
| 2022-12-31 | $75.79M 10-K · filed 2026-03-04 |
| 2022-09-30 | $79.38M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $64.19M 10-Q · filed 2023-08-08 |
| 2022-03-31 | $46.93M 10-Q · filed 2023-05-09 |
| 2021-12-31 | $21.49M 10-K · filed 2025-03-20 |
| 2021-09-30 | $24.55M 10-Q · filed 2022-11-03 |
| 2021-06-30 | $25.21M 10-Q · filed 2022-08-08 |
| 2021-03-31 | $35.76M 10-Q · filed 2022-05-09 |
| 2020-12-31 | $68.02M 10-K · filed 2024-03-14 |
| 2020-09-30 | $205.71M 10-Q · filed 2021-11-04 |
| 2020-06-30 | $160.83M 10-Q · filed 2021-08-02 |
| 2020-03-31 | $170.73M 10-Q · filed 2021-05-11 |
| 2019-12-31 | $79.26M 10-K · filed 2023-03-14 |
| 2019-09-30 | $104.06M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $113.82M 10-Q · filed 2020-08-10 |
| 2019-03-31 | $92.27M 10-Q · filed 2020-05-07 |
| 2018-12-31 | $130.61M 10-K · filed 2022-03-28 |
| 2018-09-30 | $131.13M 10-Q · filed 2019-10-30 |
| 2018-06-30 | $169.09M 10-Q · filed 2019-08-01 |
| 2018-03-31 | $64.62M 10-Q · filed 2019-05-09 |
| 2017-12-31 | $82.34M 10-K · filed 2021-03-18 |
| 2017-09-30 | $51.43M 10-Q · filed 2018-11-07 |
| 2017-06-30 | $27.75M 10-Q · filed 2018-08-08 |
| 2017-03-31 | $28.34M 10-Q · filed 2018-05-03 |
| 2016-12-31 | $32.51M 10-K · filed 2020-03-11 |
| 2015-12-31 | $25.07M 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 |